Mitchell Kapoor
Stock Analyst at H.C. Wainwright
Total Price Targets
22
Stocks Covered
14
Sectors
Healthcare
Most Recent
Feb 17, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Mitchell Kapoor
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| TYRA | Tyra Biosciences, Inc. | $45.00 | $34.09 | +32.0% | 4 | Feb 17, 2026 |
| EVMN | Evommune, Inc. | $65.00 | $24.37 | +166.7% | 2 | Feb 10, 2026 |
| LXEO | Lexeo Therapeutics, Inc. Common Stock | $10.00 | $5.82 | +71.8% | 1 | Jan 13, 2026 |
| ALMS | Alumis Inc. Common Stock | $20.00 | $25.27 | -20.9% | 2 | Dec 18, 2025 |
| MGTX | MeiraGTx Holdings plc | $20.00 | $9.46 | +111.5% | 1 | Nov 24, 2025 |
| NTLA | Intellia Therapeutics, Inc. | $18.00 | $13.20 | +36.4% | 2 | Oct 30, 2025 |
| ORKA | Oruka Therapeutics, Inc. | $40.00 | $62.83 | -36.3% | 1 | Oct 27, 2025 |
| IONS | Ionis Pharmaceuticals, Inc. | $95.00 | $75.86 | +25.2% | 1 | Sep 2, 2025 |
| ZURA | Zura Bio Limited | $3.00 | $5.21 | -42.4% | 2 | Apr 3, 2025 |
| NGNE | Neurogene Inc. | $50.00 | $27.11 | +84.4% | 2 | Mar 25, 2025 |
| CRSP | CRISPR Therapeutics AG | $65.00 | $51.72 | +25.7% | 1 | Feb 3, 2025 |
| IPSC | Century Therapeutics, Inc. | $5.00 | $2.33 | +114.1% | 1 | Nov 6, 2024 |
| SMMT | Summit Therapeutics Inc. | $45.00 | $16.11 | +179.3% | 1 | Sep 16, 2024 |
| HALO | Halozyme Therapeutics, Inc. | $65.00 | $64.04 | +1.5% | 1 | Jun 7, 2024 |
Recent Activity
- Feb 17, 2026— Set$45.00price target onTYRA(Tyra Biosciences, Inc.)
- Feb 10, 2026— Set$65.00price target onEVMN(Evommune, Inc.)
- Jan 13, 2026— Set$10.00price target onLXEO(Lexeo Therapeutics, Inc. Common Stock)
- Jan 6, 2026— Set$35.00price target onEVMN(Evommune, Inc.)
- Dec 18, 2025— Set$20.00price target onALMS(Alumis Inc. Common Stock)
- Nov 24, 2025— Set$20.00price target onMGTX(MeiraGTx Holdings plc)
- Oct 30, 2025— Set$18.00price target onNTLA(Intellia Therapeutics, Inc.)
- Oct 27, 2025— Set$40.00price target onORKA(Oruka Therapeutics, Inc.)
- Oct 27, 2025— Set$25.00price target onNTLA(Intellia Therapeutics, Inc.)
- Sep 2, 2025— Set$95.00price target onIONS(Ionis Pharmaceuticals, Inc.)
- Apr 3, 2025— Set$3.00price target onZURA(Zura Bio Limited)
- Mar 25, 2025— Set$50.00price target onNGNE(Neurogene Inc.)
- Feb 3, 2025— Set$65.00price target onCRSP(CRISPR Therapeutics AG)
- Nov 11, 2024— Set$30.00price target onTYRA(Tyra Biosciences, Inc.)
- Nov 6, 2024— Set$5.00price target onIPSC(Century Therapeutics, Inc.)
- Oct 17, 2024— Set$30.00price target onALMS(Alumis Inc. Common Stock)
- Sep 16, 2024— Set$45.00price target onSMMT(Summit Therapeutics Inc.)
- Sep 5, 2024— Set$5.00price target onZURA(Zura Bio Limited)
- Aug 12, 2024— Set$49.00price target onNGNE(Neurogene Inc.)
- Aug 8, 2024— Set$25.00price target onTYRA(Tyra Biosciences, Inc.)
Frequently Asked Questions
Who is Mitchell Kapoor?
Mitchell Kapoor is a stock analyst at H.C. Wainwright covering 14 stocks primarily in Healthcare. They have issued 22 price targets since Mar 20, 2024.
What stocks does Mitchell Kapoor cover?
Mitchell Kapoor currently covers 14 stocks, including TYRA, EVMN, ALMS, NTLA, ZURA.
What is Mitchell Kapoor's latest price target?
Mitchell Kapoor's most recent price target was $45.00 on TYRA (Tyra Biosciences, Inc.), set on Feb 17, 2026.
What is Mitchell Kapoor's highest price target?
Mitchell Kapoor's highest issued price target is $95.00 on IONS, set on Sep 2, 2025.
More Analysts at H.C. Wainwright
Coverage based on publicly published price targets. Not investment advice.